NYMC Research Well Represented at Touro Research Day
Event Included Keynote by NYMC Alumna Lorah Perell, Ph.D. '94
Touro University (TU) hosted its third institution-wide Research Day, on May 9, at the Cross River Campus at 3 Times Square. The day brought together a vast community of students and faculty, in-person and online, and recognized the multitude of research-based projects being actively carried out. This year’s theme was "Resilience and Persistence."
“Research Day is but a small window into the world of change that we effect. Touro University schools from across the country are well represented today and provide clear evidence of our growing enterprise as an important academic research institution, particularly in medicine and the allied health sciences,” Alan Kadish, M.D., president of TU and NYMC, wrote in his remarks in the program.
“Each year, I am enthralled by the passion I see in our esteemed community and the tenacity in both our established and budding scientists as they too make strides towards achieving the milestones they have set in their individual careers,” wrote Salomon Amar, D.D.S., Ph.D., vice president for research and professor of pharmacology and of pathology, microbiology and immunology at NYMC and senior vice president for research affairs at TU, who organized the event and led the intercampus planning committee. “In years prior, we have celebrated our past achievements, shared hopes for the future and for those with whom we collaborate. However, equally important to ingenuity and collaboration are resilience and persistence, as they are key factors in how a scientist will fare, be they a pupil or a well-established innovator.”
This year’s keynote speaker was NYMC alumnus Lorah Perlee, Ph.D., vice president of strategic program direction and hematology and global program head at Regeneron Pharmaceuticals, who shared how her team developed Veopoz, the first FDA-approved drug to treat CHAPLE disease, a rare, little-understood genetic condition.
New to this year's event was the TouroConnects Innovation Forum where leaders from the Touro community had the opportunity to share their research programs, discuss opportunities for collaboration across all of the schools, and explore avenues for innovation.
NYMC Winners at 2024 Touro Research Day
Applied, Clinical and Translational Research Category:
First Place: Madelaine McElrath, SOM Class of 2025
“#HormonalBirthControl: Birth Control Talk on TikTok”
Basic Sciences and Natural Sciences Category:
First Place: Kaci Kopec, photo left, Ph.D. candidate in the Department of Pathology, Microbiology and Immunology (Kopec was selected to present at the outstanding poster presentation session.)
“All-trans retinoic acid (ATRA) reduces carcinogenicity of anaplastic thyroid cancer through modulation of differentiation gene driver HOXD4”
Public Health, Epidemiology and Health Sciences Category:
First Place: Rachel Spronz, SOM Class of 2025
“Changes in School-Age Children’s Wellbeing and School-Related Needs post COVID-19 Pandemic”
Anish R. Maskey, Ph.D. '23, photo right, postdoctoral fellow in the Department of Pathology, Microbiology and Immunology, was also selected to present at the outstanding poster presentation session. He presented "Inhibition of TNF-alpha production and mast cell degradation, induced by Staphylococcus aureus isolated from eczema skin swabs, using natural compound Berberine."
View the complete list of NYMC presentations at Touro Research Day.
Videos of the 2024 Touro Research Day and other Touro Research Day videos are available on the TU Youtube Channel.
